Cellectar biosciences strengthens intellectual property protection for its pdc platform

Expanded global patent provides protection for phospholipid drug conjugate™ (pdc) platform to deliver flavaglines as targeted anticancer payloads expanded global patent provides protection for phospholipid drug conjugate™ (pdc) platform to deliver flavaglines as targeted anticancer payloads

CLRB Ratings Summary

CLRB Quant Ranking